{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T14:38:42Z","timestamp":1693924722161},"reference-count":0,"publisher":"AME Publishing Company","issue":"S26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Thorac. Dis."],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.21037\/jtd.2018.07.105","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T07:04:23Z","timestamp":1537340663000},"page":"S3124-S3127","source":"Crossref","is-referenced-by-count":1,"title":["Review of nintedanib plus pemetrexed\/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso trial"],"prefix":"10.21037","volume":"10","author":[{"given":"Pyng","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8611","published-online":{"date-parts":[[2018,9]]},"container-title":["Journal of Thoracic Disease"],"original-title":[],"link":[{"URL":"http:\/\/jtd.amegroups.com\/article\/download\/23099\/17552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T07:04:30Z","timestamp":1537340670000},"score":1,"resource":{"primary":{"URL":"http:\/\/jtd.amegroups.com\/article\/view\/23099\/18114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":0,"journal-issue":{"issue":"S26","published-online":{"date-parts":[[2018,9]]},"published-print":{"date-parts":[[2018,9]]}},"URL":"https:\/\/doi.org\/10.21037\/jtd.2018.07.105","relation":{},"ISSN":["2072-1439","2077-6624"],"issn-type":[{"value":"2072-1439","type":"print"},{"value":"2077-6624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}